Other languages Venus Remedies Limited NSE India S.E.

Equities

VENUSREM

INE411B01019

Market Closed - NSE India S.E. Other stock markets 07:49:11 2024-05-14 EDT			5-day change	1st Jan Change
297.8 ^INR	+1.03%		-4.92%	-26.71%

03-19	Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs	MT
03-08	Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs	03-19
Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products	03-08
Venus Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14
Venus Remedies Gets Ukraine Marketing Approval for Chemotherapy Drug, Antibiotics	02-13
Indian Equities Clock Sharp Losses on Wednesday Due to Widespread Selling	12-20
Indian Equities Score Another Record Highs on Tuesday, Lifted by Ruling Party's State Polls Win	12-05
Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and Philippines	12-01
Venus Remedies' Consolidated Profit Jumps in Fiscal Q2	11-27
Venus Remedies Limited Receives Marketing Approval from the Philippines for Six Key Chemotherapy Drugs	23-10-16
Venus Remedies Limited Expands Global Reach with the Launch of Elores in Ecuador	23-10-12
Venus Remedies Limited Extends Its Oncology Portfolio in South Eastern Europe with Serbian Marketing Approval for Gemcitabine and Docetaxel	23-09-20
Venus Remedies Launches its R&D Drug Elores, in the $1.4 Billion Pharmaceutical Market in Oman	23-08-17
Venus Remedies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14
Indian Equities Close Higher as US, Eurozone Inflation Cools	23-07-31
Venus Remedies Limited Extends Its Reach in the Association of Southeast Asian Nations Region, South America and Eastern Europe with Marketing Authorization for Key Cancer Drugs from Philippines, Paraguay, Georgia and Moldova	23-07-31
Venus Remedies Limited Consolidates its Position in the Guff Cooperation Council, Association of South East Asian Nations	23-07-05
Venus Remedies Limited Receives Ukrainian GMP Approval for Its Carbapenem, Oncology Parenteral Facilities	23-06-07
Venus Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-29
Venus Remedies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-29
Venus Remedies Limited Announces Resignation of Pravindra Singh Chauhan as Independent Director	23-04-04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Venus Remedies Limited NSE India S.E.

Equities

VENUSREM

INE411B01019

Other languages

Filters